These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33173597)

  • 1. Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.
    Neganova ME; Aleksandrova YR; Nebogatikov VO; Klochkov SG; Ustyugov AA
    Acta Naturae; 2020; 12(3):60-80. PubMed ID: 33173597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?
    Gladkova MG; Leidmaa E; Anderzhanova EA
    Cells; 2023 May; 12(11):. PubMed ID: 37296584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.
    Riederer P; Nagatsu T; Youdim MBH; Wulf M; Dijkstra JM; Sian-Huelsmann J
    J Neural Transm (Vienna); 2023 May; 130(5):627-646. PubMed ID: 37062012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser
    Means JC; Lopez AA; Koulen P
    Cell Mol Neurobiol; 2020 Aug; 40(6):911-926. PubMed ID: 31919747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
    Çınar E; Tel BC; Şahin G
    Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders.
    Sebastiani G; Almeida-Toledano L; Serra-Delgado M; Navarro-Tapia E; Sailer S; Valverde O; Garcia-Algar O; Andreu-Fernández V
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
    Gerszon J; Rodacka A
    Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation.
    Karvandi MS; Sheikhzadeh Hesari F; Aref AR; Mahdavi M
    Front Cell Neurosci; 2023; 17():1105247. PubMed ID: 36950516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
    Sengupta U; Kayed R
    Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases.
    Goldsteins G; Hakosalo V; Jaronen M; Keuters MH; Lehtonen Š; Koistinaho J
    Antioxidants (Basel); 2022 Feb; 11(2):. PubMed ID: 35204286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial
    Ganai SA; Abdullah E; Rashid R; Altaf M
    Front Mol Neurosci; 2017; 10():357. PubMed ID: 29170627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection.
    Shoaib S; Ansari MA; Fatease AA; Safhi AY; Hani U; Jahan R; Alomary MN; Ansari MN; Ahmed N; Wahab S; Ahmad W; Yusuf N; Islam N
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases.
    Aleksandrova Y; Neganova M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?
    Windisch M; Wolf HJ; Hutter-Paier B; Hofmeister A; Wronski R
    Curr Alzheimer Res; 2007 Sep; 4(4):446-57. PubMed ID: 17908049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.